Why the study?
Does fluvastatin alter platelet aggregability in patients with hypercholesterolemia?
Does fluvastatin alter platelet aggregability in patients with hypercholesterolemia?
Fluvastatin reduces platelet aggregability in hypercholesterolemic patients through cholesterol-independent mechanisms involving improved intraplatelet redox balance.
No takes yet. Share an insight, caveat, or question.
Fluvastatin may confer antiplatelet benefits beyond LDL-C lowering; extends RCT evidence for statin pleiotropy via redox mechanisms.
Haramaki et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: